StonvexLoading…
StonvexStonvexStonvexCore line items from TNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $297.90M | $1.20B | $911.90M | $608.60M |
Operating Income | $4.90M | $68.30M | $72.50M | $50.20M |
Net Income | $200.00K | $43.80M | $48.20M | $33.30M |
EPS (Diluted) | $0.01 | $2.36 | $2.57 | $1.77 |
Total Assets | $1.28B | $1.27B | $1.26B | $1.24B |
Total Liabilities | $743.60M | $665.50M | $614.20M | $587.80M |
Cash & Equivalents | $82.60M | $106.40M | $99.40M | $80.10M |
Free Cash Flow OCF − CapEx | $-34.40M | $43.30M | $33.60M | $11.30M |
Shares Outstanding | 17.04M | 17.85M | 18.26M | 18.53M |